nach oben

Strahlentherapie und Onkologie

Erschienen in:

01.03.2012 | Original article

Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer

verfasst von: M.N. Duma, S. Kampfer, T. Schuster, C. Winkler, H. Geinitz

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The goal of the present study was to assess the frequency and impact of replanning triggered solely by soft tissue changes observed on the daily setup mega-voltage CT (MVCT) in head and neck cancer (H&N) helical tomotherapy (HT).

Material and methods

A total of 11 patients underwent adaptive radiotherapy (ART) using MVCT. Preconditions were a soft tissue change > 0.5 cm and a tight mask. The dose–volume histograms (DVHs) derived from the initial planning kVCT (inPlan), the recalculated DVHs of the fraction (fx) when replanning was decided (actSit) and the DVHs of the new plan (adaptPlan) were compared. Assessed were the following: maximum dose (D_max), minimum dose (D_min), and mean dose (D_mean) to the planning target volume (PTV) normalized to the prescribed dose; the D_mean/fx to the parotid glands (PG), oral cavity (OC), and larynx (Lx); and the D_max/fx to the spinal cord (SC) in Gy/fx.

Results

No patient had palpable soft tissue changes. The median weight loss at the moment of replanning was 2.3 kg. The median PTV D_mean was 100% for inPlan, 103% for actSit, and 100% for adaptPlan. The PTV was always covered by the prescribed dose. A statistically significant increase was noted for all organs at risk (OAR) in the actSit. The D_mean to the Lx, the D_mean to the OC and the D_max to the SC were statistically better in the adaptPlan. No statistically significant improvement was achieved by ART for the PGs. No significant correlations between weight and volume loss or between the volume changes of the organs to each other were observed, except a strong positive correlation of the shrinkage of the PGs (ρ = + 0.77, p = 0.005).

Conclusion

Soft tissue shrinkage without clinical palpable changes will not affect the coverage of the PTV, but translates into a higher delivered dose to the PTV itself and the normal tissue outside the PTV. The gain by ART in individual patients—especially in patients who receive doses close to the tolerance doses of the OAR—could be substantial.

Ahn PH, Chen CC, Ahn AI et al (2011) Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications. Int J Radiat Oncol Biol Phys 80:677–685PubMedCrossRef

Barker JL Jr, Garden AS, Ang KK et al (2004) Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59:960–970PubMedCrossRef

Boda-Heggemann J, Lohr F, Wenz F et al (2011) kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol 187:284–291PubMedCrossRef

Budach W, Bolke E, Fietkau R et al (2011) Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial. Strahlenther Onkol 187:449–460PubMedCrossRef

Burman C, Kutcher GJ, Emami B, Goitein M (1991) Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21:123–135PubMedCrossRef

Castadot P, Lee JA, Geets X, Gregoire V (2010) Adaptive radiotherapy of head and neck cancer. Semin Radiat Oncol 20:84–93PubMedCrossRef

Chao KS, Wippold FJ, Ozyigit G et al (2002) Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 53:1174–1184PubMedCrossRef

Deasy JO, Blanco AI, Clark VH (2003) CERR: a computational environment for radiotherapy research. Med Phys 30:979–985PubMedCrossRef

Duma MN, Kampfer S, Wilkens JJ et al (2010) Comparative analysis of an image-guided versus a non-image-guided setup approach in terms of delivered dose to the parotid glands in head-and-neck cancer IMRT. Int J Radiat Oncol Biol Phys 77:1266–1273PubMedCrossRef

10.

Farrag A, Voordeckers M, Tournel K et al (2010) Pattern of failure after helical tomotherapy in head and neck cancer. Strahlenther Onkol 186:511–516PubMedCrossRef

11.

Geets X, Tomsej M, Lee JA et al (2007) Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 85:105–115PubMedCrossRef

12.

Gregoire V, Eisbruch A, Hamoir M, Levendag P (2006) Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79:15–20PubMedCrossRef

13.

Hansen EK, Bucci MK, Quivey JM et al (2006) Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 64:355–362PubMedCrossRef

14.

Kreppel M, Drebber U, Eich HT et al (2011) Combined-modality treatment in advanced oral squamous cell carcinoma: primary surgery followed by adjuvant concomitant radiochemotherapy. Strahlenther Onkol 187:555–560PubMedCrossRef

15.

Lee C, Langen KM, Lu W et al (2008) Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol 89:81–88PubMedCrossRef

16.

Rancati T, Schwarz M, Allen AM et al (2010) Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 76:64–69CrossRef

17.

Robar JL, Day A, Clancey J et al (2007) Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68:1121–1130PubMedCrossRef

18.

Sterzing F, Herfarth K, Debus J (2007) IGRT with helical tomotherapy-effort and benefit in clinical routine. Strahlenther Onkol 183(2):35–37PubMedCrossRef

19.

Stock M, Dorr W, Stromberger C et al (2010) Investigations on parotid gland recovery after IMRT in head and neck tumor patients. Strahlenther Onkol 186:665–671PubMedCrossRef

20.

Vasquez Osorio EM, Hoogeman MS, Al-Mamgani A et al (2008) Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. Int J Radiat Oncol Biol Phys 70:875–882CrossRef

21.

Welsh JS, Lock M, Harari PM et al (2006) Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technol Cancer Res Treat 5:465–479PubMed

22.

Wu Q, Chi Y, Chen PY et al (2009) Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 75:924–932PubMedCrossRef

Titel: Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer
verfasst von: M.N. Duma
S. Kampfer
T. Schuster
C. Winkler
H. Geinitz
Publikationsdatum: 01.03.2012
Verlag: Springer-Verlag
Erschienen in: Strahlentherapie und Onkologie / Ausgabe 3/2012
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-011-0041-8

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer

Abstract

Purpose

Material and methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Material and methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer

RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma

Radiotherapy in elderly patients with inoperable esophageal cancer

Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck

Extrapulmonale kleinzellige Karzinome: Einfluss der Strahlentherapie auf das Überleben

Radiation-induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and dose-dependent

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie